Sure. We do expect to see good growth from Casualty throughout the year. We've made considerable investments in casualty from, most importantly, a talent and leadership perspective. People like Ty Robben, Brian Pushic and Gerrit VandeKemp have come across with great pedigrees and great followings and great experience in the market. So we are investing in them from a system standpoint, from a balance sheet standpoint, from incremental underwriting resources, and want to build a meaningful franchise in these niche market segments. So what we -- I would say right now, though, is we are going into the market, and we are doing so in a meaningful fashion but also a conservative fashion, conservative from a risk selection standpoint. Whether we are avoiding severity exposed classes on the general liability side or the professional liability side, it limits management. Whether -- our max gross line is $5 million, net is $2 million. When you think about nuclear verdicts that are in the $100 million range like that, a $5 million gross line doesn't materially swing our balance sheet or our earnings base for that matter. And then, we have a lot of different underwriting controls. Again, that's informed by the strong leadership that we have in place. Where we sit right now, we feel that we are getting adequate rate to cover our loss costs. Our general casualty book was up 9.9%. We think that's against loss cost that's probably 4% to 5%. Excess liability was up 6.7%. I think it's a similar type of loss cost. It's not to say, again, as I mentioned earlier, that all lines in Casualty are getting the same level of rate or have that term rate integrity. Financial lines are tough, and we do not write a lot of that, but we do write some private company D&O inside of our miscellaneous professional liability suite, and that's not getting the rate that we'd like. So we have to be mindful of how much exposure we have there. I think the last thing that I would say is, when you look at our loss picks, we think they're conservative. They were just vetted by our reinsurance panel at 6/1 -- excuse me at 4/1 with the renewal, and we got improved terms and conditions and improved pricing there. So I think that's a validation. I think the greatest validation is our loss pick is meaningfully above the historical results of these underwriters that we brought on. So I know that's a lot, but what I would say is, we do feel good about our Casualty strategy, the niche focus, feel exceptional about the leadership we have helping us execute upon that. And we don't think that we will be releasing reserves anytime soon. So we're going to be conservatively building the reserve base.